News

The Pharma Letter2h
The week in pharma: action, reaction and insight – week to June 27
US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street ...
Notable healthcare headlines for the week: Novo Nordisk, Amgen and UnitedHealth in focus
UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...
Could YOU make a pile of cash investing in the never-ending craze for Mounjaro and Ozempic?
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Could YOU make a pile of cash from the never-ending craze for Mounjaro and Ozempic? ANNE ASHWORTH reveals everything you need to know
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Stifel Resumed Coverage on V2X, Inc (VVX), Kept the PT Unchanged
V2X, Inc. (NYSE:VVX) is one of the 13 Best Aerospace and Defense Stocks to Invest in Now. On June 23, Stifel resumed coverage ...